NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023

Stock Information for NanoString Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NanoString Technologies Inc.

NanoString Comments on Delaware District Court Verdict
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies Releases Operating Results for Third Quarter of 2023
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
10x Genomics Comments on Second UPC Preliminary Injunction Decision
A*STAR's Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.